News Decision to axe Afinitor 'confirms worst fears’ for Cancer D... NICE reviewing 'legacy drugs' to free up CDF funds
News NICE says no to liver cancer drug Nexavar Liver cancer treatment latest earmarked for removal from CDF
News Xalkori gains NICE approval after price cut NICE approval secured against background of renewed controversy
Views & Analysis NICE plans to charge for appraisals – but pharma wants refor... Will NICE introduce fees for pharma companies' TAs from next year?
News NICE recommends Amgen’s melanoma treatment after price cut Drug only approved when systemic immunotherapies are not suitable
News NHS under fire for rationing hep C drugs NHS England tried to interfere with NICE appraisals, says BMJ.
News GSK grows pipeline with 35Pharma takeover, Frontier deal GSK CEO Luke Miels signs a pair of pipeline-expanding deals, and the first acquisition on his watch, as the group prepares for a looming patent cliff.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
